IQUR
iQur is at the forefront of vaccine research and development, using tandem core technology to create novel vaccines, currently being developed for influenza, malaria, human cytomegalovirus, dengue fever and hepatitis C. At iQur we are designing vaccines to provide protection against major global health challenges. We are targeting several different viruses using our patented proprietary technology and hope to bring benefit to people around the world by protecting them against a range of major pathogens.
IQUR
Industry:
Health Care Life Science Medical Pharmaceutical
Founded:
2003-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.iqur.com
Status:
Active
Contact:
+44 20 7691 1122
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Nginx Euro
Official Site Inspections
http://www.iqur.com Semrush global rank: 5.33 M Semrush visits lastest month: 1.56 K
- Host name: staticip.multiscreensite.com
- IP address: 35.172.94.1
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "iQur"
iQur - Crunchbase Company Profile & Funding
IQur is at the forefront of vaccine research and development, using tandem core technology to create novel vaccines, currently being developed for influenza, …See details»
Leadership | Scientific & Corporate - iQur
In 2014 he joined iQur where he served as the Head of Immunology and currently as the Head of Discovery, leading the research efforts to discover new vaccine candidates using the tandem …See details»
Iqur Company Profile 2024: Valuation, Funding & Investors
Iqur General Information Description. Operator of a vaccine research and development and molecular diagnostics firm headquartered in London, England. The company uses its …See details»
iQur Company Profile - Office Locations, Competitors, Revenue
IQur is a company that engages in vaccine research and development and molecular diagnostics. It develops vaccines for infectious diseases, including a universal influenza vaccine, vaccines …See details»
Contact us - iQur
If you would like more information about iQur and our research, please get in touch. Send us a message. YOUR NAME. YOUR EMAIL ADDRESS. MESSAGE. Email: [email protected]. Tel: …See details»
iQur Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Last update 01 Nov 2024. iQur Ltd. Holding Company |See details»
IQur Therapeutics - Company Profile - Tracxn
Oct 20, 2024 IQur Therapeutics ranks 140th among 362 active competitors. 110 of its competitors are funded while 81 have exited. Overall, IQur Therapeutics and its competitors …See details»
IQUR LIMITED Company Profile | LONDON, United Kingdom
Iqur limited. d&b business directory home / business directory / professional, scientific, and technical services / other professional, scientific, and technical services / united kingdom / …See details»
iQur - Crunchbase
IQur designs vaccines to provide protection against major global health challengesSee details»
iQur Ltd - Southampton, United Kingdom - bionity.com
Feb 5, 2008 iQur(r) is a specialty pharmaceutical company at the forefront of international breakthroughs in the detection, treatment and monitoring of Hepatitis C and other liver …See details»
iQur - Products, Competitors, Financials, Employees, Headquarters …
About iQur. Provider of hepatitis diagnostic solutions. The company provides diagnostic services based on molecular techniques designed to detect the presence of hepatitis C or B virus …See details»
What We Do | Vaccine Design | iQur
At iQur we are designing vaccines to provide protection against major global health challenges. Using our patented platform technology we are targeting several viruses and hope to bring …See details»
Peter - iQure Pharma
He led several projects with large and small Pharma/Biotech companies in Europe and the US helping them to establish more robust strategies and processes, e.g. supply chain, document …See details»
iQor Qares Announces New Chair to Lead Nonprofit Organization
IQor Qares is pleased to announce the appointment of Richard Eychner, iQor’s Chief Culture Officer, as the new Chair of iQor Qares, succeeding the successful tenure of Martin Lehtio, …See details»
iQor Qares
IQor Qares is a 501(c)(3) nonprofit charitable organization dedicated to helping iQor employees, their family members, and their local communities in need of financial assistance due to life …See details»
Investors | Biotech Investment Opportunities - iQur
For more on investment opportunities at iQur contact William Rosenberg. Governance The company is governed by a Board who have adopted corporate governance guidelines, to …See details»
World’s Most Sought-After Outsourced Customer Support & BPO …
Next-gen AI that drives flexibility, efficiency, and growth. Our Symphony [AI] ™ ecosystem propels innovation and excellence throughout the employee lifecycle to deliver smile-worthy CX. With …See details»
Vaccine Discovery | Vaccine Development | iQur
The vaccines that iQur is developing use virus-like particles (VLP) to stimulate the immune system and inoculate against pathogens. Our VLP vaccines can deliver selected antigens, engineered …See details»
News | Articles & Publications | iQur
Nov 9, 2005 iQur Ltd Closes £2.6 Million Investment, Wins Major DoH Award For Healthcare Innovation & Signs Pipeline Agreement On Anti-Fibrosis IP 09 Nov, 2005 Advances …See details»